Peptide research continues to expand, and two of the most discussed compounds in soft tissue and mobility models are BPC-157 and TB-500. This post provides a clear breakdown of both, focusing on reported properties, usage direction in lab settings, and suggested research doses.
Strictly for scientific research only.
BPC-157 (Body Protective Compound) is a synthetic peptide derived from a protein found in the gastric system.
In laboratory research, it has been associated with:
It’s highly water-soluble and often reconstituted with bacteriostatic water.
TB-500 is a synthetic peptide modeled after a segment of Thymosin Beta-4, which is present in nearly all animal cells.
In research models, TB-500 has been used to explore:
Known for its broader systemic effects in experimental applications.
Values are derived from animal model studies and public research references.
Some researchers co-study BPC-157 and TB-500 together:
This information is for educational and scientific purposes only.
All peptides mentioned are not for human or veterinary use, and are intended for research use only. Always follow local compliance protocols and lab safety procedures.
Have you conducted research with BPC-157 or TB-500?
Share your questions, study design ideas, or general feedback below
Let’s build a stronger research community together.
Strictly for scientific research only.
What is BPC-157?
BPC-157 (Body Protective Compound) is a synthetic peptide derived from a protein found in the gastric system.
In laboratory research, it has been associated with:
- Support for cell migration and angiogenesis
- Research in tendon, ligament, and gastrointestinal models
- Studies on oxidative balance and cellular repair responses
It’s highly water-soluble and often reconstituted with bacteriostatic water. What is TB-500?
TB-500 is a synthetic peptide modeled after a segment of Thymosin Beta-4, which is present in nearly all animal cells.
In research models, TB-500 has been used to explore:
- Actin regulation and cell structure support
- Systemic tissue flexibility and inflammation-related studies
- Muscular and fascia regeneration processes
Known for its broader systemic effects in experimental applications.
BPC-157 vs TB-500 — Key Differences
- Focus
BPC-157: Localized soft tissue (e.g. tendons, GI)
TB-500: Systemic repair and muscle tissue studies - Solubility
Both are water-soluble and typically reconstituted with BAC water - Common Vial Sizes
BPC-157: 5mg or 10mg
TB-500: 2mg or 5mg
Suggested Research Doses & Lab Use
- BPC-157
Reconstitution: BAC water
Research use: 250–500 mcg per session
Study frequency: Once daily or every other day - TB-500
Reconstitution: BAC water
Research use: 1–2 mg per session
Study frequency: Weekly or bi-weekly intervals over 4–6 weeks
Values are derived from animal model studies and public research references.
Combined Research Use
Some researchers co-study BPC-157 and TB-500 together:
- BPC-157: localized cell support
- TB-500: broad tissue mobility and recovery models
- The two are often combined in tendon, muscle, and injury recovery frameworks
Standard Lab Formats
- BPC-157 → 5mg or 10mg (lyophilized powder)
- TB-500 → 2mg or 5mg (lyophilized powder)
- Solvent: 0.22µm filtered bacteriostatic water recommended
Research Use Only
This information is for educational and scientific purposes only.
All peptides mentioned are not for human or veterinary use, and are intended for research use only. Always follow local compliance protocols and lab safety procedures.
Join the Discussion
Have you conducted research with BPC-157 or TB-500?
Share your questions, study design ideas, or general feedback below
Let’s build a stronger research community together.
